Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CFDP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKTIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLAC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF114 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UTRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCOLN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF277 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NNT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPRIPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNF4G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1G1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HINT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBFB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on